Valdés L, San José E, Alvarez D, Valle J M
Sección de Neumología, Hospital de Conxo, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
Eur Respir J. 1996 Apr;9(4):747-51. doi: 10.1183/09031936.96.09040747.
The rise in adenosine deaminase (ADA) activity in the pleural fluid of tuberculous pleurisy patients, though used for diagnosis, is of unknown origin. In this work, we determined ADA activity and the activities of 2'-deoxyadenosine deaminase and ADA-2 in 350 patients. We also considered whether the results throw light on the origin of high pleural fluid ADA in tuberculous pleurisy and estimated the diagnostic efficiency of 2'-deoxyadenosine deaminase, ADA-2 and total ADA activities with and without the inclusion of the 2'-deoxyadenosine deaminase/ADA activity ratio in a combined criterion. The 350 pleural effusions were classified by previously established criteria as transudates (60 males/18 females) or as tuberculous (49 males/27 females), neoplastic (50 males/39 females), parapneumonic (36 males/19 females), empyematous (11 males/3 females), or miscellaneous (25 males/13 females) exudates. Total ADA, ADA-2 and 2'-deoxyadenosine deaminase activities were, respectively, 127.5 +/- 2.9, 103 +/- 29.5 and 42.8 +/- 14 U.L-1 in tuberculous exudates. With diagnostic thresholds of 47, 40 and 22 U.L-1 respectively, the sensitivities of ADA, ADA-2 and 2'-deoxyadenosine deaminase for tuberculosis were 100, 100 and 95%; their specificities 91, 96 and 92%; and their efficiencies 93, 97 and 93%, respectively. One hundred and one effusions (all 76 tuberculous, 12 neoplastic, 4 parapneumonic and 9 empyematous exudates) had total ADA levels > 47 U.L-1; of these, 8 neoplastic, 1 parapneumonic and all the tuberculous exudates had a 2'-deoxyadenosine deaminase/ADA activity ratio < 0.49. The criterion of simultaneously having ADA > 47 U.L-1, ADA-2 > 40 U.L-1 and a 2'-deoxyadenosine deaminase/ADA activity ratio < 0.49 was satisfied by all the tuberculous effusions but only eight others (all neoplastic) (sensitivity 100%, specificity 97%, efficiency 98%). We conclude that: 1) high total ADA activity in tuberculous pleural effusions is due mainly to an increase in ADA-2, and, therefore, originated from the only known source monocytes and macrophages; 2) ADA-2 was a more efficient diagnostic marker of tuberculous pleurisy than total ADA activity, although the difference was not statistically significant; and 3) among effusions with high total ADA the 2'-deoxyadenosine deaminase/ADA activity ratio differentiates tuberculous effusions from empyemas and parapneumonic effusions, but fails to discriminate well between tuberculous and neoplastic effusions.
结核性胸膜炎患者胸腔积液中腺苷脱氨酶(ADA)活性升高,虽用于诊断,但其来源不明。在本研究中,我们测定了350例患者的ADA活性以及2'-脱氧腺苷脱氨酶和ADA-2的活性。我们还探讨了这些结果是否有助于阐明结核性胸膜炎患者胸腔积液中ADA升高的来源,并评估了在联合诊断标准中纳入或不纳入2'-脱氧腺苷脱氨酶/ADA活性比值时,2'-脱氧腺苷脱氨酶、ADA-2和总ADA活性的诊断效能。根据先前制定的标准,350例胸腔积液被分类为漏出液(男性60例/女性18例)或渗出液,其中渗出液又分为结核性(男性49例/女性27例)、肿瘤性(男性50例/女性39例)、肺炎旁性(男性36例/女性19例)、脓性(男性11例/女性3例)或其他(男性25例/女性13例)。结核性渗出液中总ADA、ADA-2和2'-脱氧腺苷脱氨酶活性分别为127.5±2.9、103±29.5和42.8±14 U·L⁻¹。ADA、ADA-2和2'-脱氧腺苷脱氨酶对结核病的诊断阈值分别为47、40和22 U·L⁻¹,其敏感性分别为100%、100%和95%;特异性分别为91%、96%和92%;诊断效能分别为93%、97%和93%。101例胸腔积液(76例结核性、12例肿瘤性、4例肺炎旁性和9例脓性渗出液)的总ADA水平>47 U·L⁻¹;其中,8例肿瘤性、1例肺炎旁性和所有结核性渗出液的2'-脱氧腺苷脱氨酶/ADA活性比值<0.49。所有结核性胸腔积液均满足ADA>47 U·L⁻¹、ADA-2>40 U·L⁻¹且2'-脱氧腺苷脱氨酶/ADA活性比值<0.49这一标准,但仅8例其他胸腔积液(均为肿瘤性)满足该标准(敏感性100%,特异性97%,诊断效能98%)。我们得出以下结论:1)结核性胸腔积液中总ADA活性升高主要是由于ADA-2增加,因此来源于唯一已知的来源单核细胞和巨噬细胞;2)ADA-2是比总ADA活性更有效的结核性胸膜炎诊断标志物,尽管差异无统计学意义;3)在总ADA水平较高的胸腔积液中,2'-脱氧腺苷脱氨酶/ADA活性比值可区分结核性胸腔积液与脓性胸腔积液和肺炎旁性胸腔积液,但在结核性和肿瘤性胸腔积液之间鉴别效果不佳。